HealthCentral.com

Pneumonia - References




References

Little P, Rumsby K, Kelly J,et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA. 2005;293(24):3029-3035.

Rainer, TH. Severe Acute Respiratory Syndrome: Clinical Features, Diagnosis, and Management. Curr Opin Pulm Med.10(3):159-165, 2004.

Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid?suppressive drugs. JAMA. 2004;292:1955-1960.

Yang ZY, Kong WP, Huang Y,et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 2004;428(6982):561-564.



Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C; Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003;37(11):1405-1433.

Apisarnthanarak A, Mundy LM. Etiology of Community-Acquired Pneumonia. Clin Chest Med. 2005;26:47-55.

Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for pneumocystis from humans. Emerg Infect Dis [serial online] 2002;8.

Cohen J, Powderly WG, Berkley SF, et al. eds. Infectious Diseases. 2nd ed. New York, NY: Mosby; 2004:703-706.

Whitty JE, Dombrowski MP. Respiratory Disease in Pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL, et al. eds. Obstetrics: Normal and Problem Pregnancies. 4th ed. New York, NY: Churchill Livingstone; 2002:1033-36.

US Food and Drug Administration. Product Safety Alerts: Tequin (gatifloxacin). Created: February 15, 2006. Rockville, MD; February 22, 2006.

Centers for Disease Control and Prevention. CDC Health Alert: CDC Recommends against the Use of Amantadine and Rimantadine for the Treatment or Prophylaxis of Influenza in the United States during the 2005-06 Influenza Season. Posted January 14, 2006.




Symptoms Checker